secwatch.observer — SEC 8-K summary
======================================

Issuer:     SpringWorks Therapeutics, Inc. (—)
CIK:        0001773427
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001104659-25-064445
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Merck KGaA completes acquisition of SpringWorks Therapeutics for $47.00 per share
--------------------------------------------------------------------------------

- Merger closed on July 1, 2025; SpringWorks becomes wholly owned subsidiary of Merck KGaA.
- Shareholders received $47.00 per share in cash; shares of SWTX delisted from Nasdaq.
- Board of directors and officers resigned; new directors and officers appointed by Merck KGaA.
- Certificate of incorporation and bylaws amended and restated effective at closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773427/000110465925064445/0001104659-25-064445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773427/000110465925064445/tm2519396d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-064445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer